GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alk-Abello AS (CHIX:ALKBc) » Definitions » Short-Term Debt

Alk-Abello AS (CHIX:ALKBC) Short-Term Debt : kr19 Mil (As of Sep. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Alk-Abello AS Short-Term Debt?

Alk-Abello AS's Short-Term Debt for the quarter that ended in Sep. 2024 was kr19 Mil.

Alk-Abello AS's quarterly Short-Term Debt stayed the same from Mar. 2024 (kr19 Mil) to Jun. 2024 (kr19 Mil) and stayed the same from Jun. 2024 (kr19 Mil) to Sep. 2024 (kr19 Mil).

Alk-Abello AS's annual Short-Term Debt declined from Dec. 2021 (kr244 Mil) to Dec. 2022 (kr226 Mil) but then increased from Dec. 2022 (kr226 Mil) to Dec. 2023 (kr280 Mil).

Alk-Abello AS Short-Term Debt Historical Data

The historical data trend for Alk-Abello AS's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alk-Abello AS Short-Term Debt Chart

Alk-Abello AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.00 18.00 244.00 226.00 280.00

Alk-Abello AS Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 224.00 280.00 19.00 19.00 19.00

Alk-Abello AS Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Alk-Abello AS Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Alk-Abello AS's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Alk-Abello AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alk-Abello AS (CHIX:ALKBc) » Definitions » Short-Term Debt
Comparable Companies
OCSE:BAVA OCSE:ZEAL OCSE:GUBRA OCSE:PEG OCSE:GMAB VRTX REGN ASX:CSL XKRX:207940 XBRU:UCB ALNY XBRU:ARGX XKRX:068270 BNTX BGNE MRNA SMMT UTHR XKRX:196170 PCVX
Traded in Other Exchanges
AKBLF:USA 0OIR:UK ALK B:Denmark 4AJ0:Germany
Address
Boge Alle 6-8, Horsholm, DNK, DK-2970
Website
https://www.alk.net
Alk-Abello AS is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication. The company operates in Europe, North America and International Markets. It derives maximum revenue from Europe.

Alk-Abello AS Headlines

No Headlines